Citable company snapshot
DEXCOM INC's latest SEC-sourced 2026-06-30 period shows $1.31B in revenue and $249.10M in net income.
| Metric | Latest period | Latest value | Prior value | YoY |
|---|---|---|---|---|
| Revenue | Jun 30, 2026 | $1.31B | $1.19B | +9.8% |
| Gross Profit | Jun 30, 2026 | $830.00M | $750.30M | +10.6% |
| Operating Income | Jun 30, 2026 | $318.30M | $255.30M | +24.7% |
| Net Income | Jun 30, 2026 | $249.10M | $199.50M | +24.9% |
| Operating Cash Flow (computed) | Jun 30, 2026 | $269.20M | $525.60M | -48.8% |
| Free Cash Flow (computed) | Jun 30, 2026 | $184.50M | $449.00M | -58.9% |
Source: SEC EDGAR financial statements; period Jun 30, 2026; filed Jul 30, 2026; accession 0001093557-26-000143.
DXCM company research is available with Aerarium Pro (CAD $10/mo). The five showcase tickers (TSLA, NVDA, AAPL, AMZN, PLTR) and the macro dashboard stay free. Already a subscriber? Sign in to pick up where you left off.